Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kazuhiro Makitani"'
Autor:
Hironobu Ihira, Tetsuo Sonomura, Ayano Makitani, Kazuhiro Makitani, Kodai Fukuda, Ryota Tanaka, Takao Koyama, Hirotatsu Sato, Ke Wan, Masaki Ueno, Yoshiyuki Ida, Nobuyuki Kawai, Hiroki Minamiguchi
Publikováno v:
JGH Open, Vol 7, Iss 12, Pp 884-888 (2023)
Abstract Background and Aim Transcatheter arterial chemoembolization (TACE) using various anticancer drugs is often performed to treat hepatocellular carcinoma (HCC). We aimed to compare the therapeutic efficacy and side effects of TACE with anticanc
Externí odkaz:
https://doaj.org/article/b649e21ae6f14e8abf4eae5ae13fee16
Publikováno v:
Journal of hepatocellular carcinoma. 9
Shota Ueda,1 Shinichi Hori,2 Atsushi Hori,2 Kazuhiro Makitani,2 Ke Wan,3 Tetsuo Sonomura1 1Department of Radiology, Wakayama Medical University, Wakayama, Japan; 2Department of Radiology, Institute for Image Guided Therapy, Izumisano City, Osaka, Jap
Publikováno v:
BJR|case reports. 8
Intrahepatic cholangiocarcinoma is hardly diagnosed in early stages as the symptoms are non-specific. Due to an advanced stages at the time of first diagnosis, the therapeutic options for patients with unresectable cholangiocarcinoma are mostly limit
Autor:
Atsufumi Kamisako, Akira Ikoma, Masataka Koike, Kazuhiro Makitani, Kodai Fukuda, Nobuyuki Higashino, Masahiko Shibuya, Yuji Okuno, Hiroki Minamiguchi, Tetsuo Sonomura
Publikováno v:
The Knee. 36
In recent years, transcatheter arterial embolization (TAE) using imipenem/cilastatin (IPM/CS) has attracted attention as a treatment for relieving osteoarthritis (OA) pain. However, IPM/CS is not approved by Japanese medical insurance for use as an e